Yong-Su Zhen Selected Research

Apoproteins

1/2018	The Recombinant and Reconstituted Novel Albumin-Lidamycin Conjugate Shows Lasting Tumor Imaging and Intensively Enhanced Therapeutic Efficacy.
12/2014	Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation.
5/2010	[Binding capability of lidamycin apoprotein to human breast cancer detected by tissue microarrays].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yong-Su Zhen Research Topics

Disease

56	Neoplasms (Cancer) 04/2022 - 02/2003
14	Carcinoma (Carcinomatosis) 11/2018 - 07/2004
12	Hepatocellular Carcinoma (Hepatoma) 01/2014 - 07/2004
10	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022 - 06/2007
7	Neoplasm Metastasis (Metastasis) 11/2018 - 12/2003
4	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2008
4	Glioma (Gliomas) 08/2014 - 07/2009
3	Fibrosarcoma 11/2018 - 01/2011
3	Multiple Myeloma 07/2013 - 07/2009
3	Lung Neoplasms (Lung Cancer) 03/2012 - 12/2003
2	Esophageal Squamous Cell Carcinoma 01/2019 - 01/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017 - 04/2017
2	Esophageal Neoplasms (Esophageal Cancer) 06/2017 - 01/2014
2	Colonic Neoplasms (Colon Cancer) 11/2016 - 06/2010
2	Colorectal Neoplasms (Colorectal Cancer) 07/2014 - 08/2005
2	Ovarian Neoplasms (Ovarian Cancer) 01/2014 - 01/2009
1	Triple Negative Breast Neoplasms 12/2021
1	Experimental Melanoma 01/2021
1	Inflammation (Inflammations) 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2017
1	Adenocarcinoma of Lung 10/2013

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2004
27	C 1027IBA 01/2018 - 06/2005
11	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 06/2005
10	Pharmaceutical PreparationsIBA 03/2022 - 10/2005
9	ErbB Receptors (EGF Receptor)IBA 12/2021 - 01/2009
6	Therapeutic UsesIBA 01/2020 - 07/2005
5	Gemcitabine FDA Link 01/2022 - 05/2008
4	Matrix Metalloproteinases (MMPs)IBA 11/2018 - 12/2003
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013 - 07/2005
4	Collagenases (Collagenase)FDA Link 06/2006 - 12/2003
3	DefensinsIBA 01/2022 - 09/2016
3	Peptides (Polypeptides)IBA 01/2022 - 03/2013
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 02/2011
3	ApoproteinsIBA 01/2018 - 05/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2014 - 06/2006
3	Fluorouracil (Carac)FDA LinkGeneric 01/2013 - 07/2004
3	rhein lysinateIBA 01/2009 - 11/2008
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2005 - 07/2004
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2022 - 12/2006
2	Immunoconjugates (Immunoconjugate)IBA 12/2021 - 01/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021 - 01/2009
2	Human Serum Albumin FDA LinkGeneric 09/2021 - 01/2018
2	ubenimexIBA 01/2020 - 12/2012
2	Drug CombinationsIBA 01/2020 - 01/2014
2	AlbuminsIBA 01/2018 - 09/2012
2	Temozolomide (Temodar)FDA LinkGeneric 08/2014 - 04/2014
2	GelatinasesIBA 04/2013 - 10/2012
2	Vincristine (Oncovin)FDA LinkGeneric 01/2013 - 12/2004
2	Antineoplastic Agents (Antineoplastics)IBA 01/2013 - 12/2006
2	Fluorescein-5-isothiocyanate (FITC)IBA 10/2012 - 04/2010
2	rheinIBA 01/2009 - 01/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2009 - 01/2009
2	NF-kappa B (NF-kB)IBA 05/2008 - 06/2007
2	UridineIBA 10/2005 - 07/2004
2	Monoclonal AntibodiesIBA 08/2005 - 12/2003
1	formaldehyde-serum albuminIBA 04/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2022
1	salinomycinIBA 01/2022
1	Epithelial Cell Adhesion MoleculeIBA 12/2021
1	ProdrugsIBA 09/2021
1	bleomycetinIBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2020
1	Capecitabine (Xeloda)FDA Link 01/2020
1	Gramicidin (Gramicidin A)FDA LinkGeneric 01/2019
1	IonophoresIBA 01/2019
1	Sincalide FDA Link 01/2019
1	Recombinant ProteinsIBA 11/2018
1	Amino Acids FDA Link 01/2018
1	LigandsIBA 06/2017
1	Epidermal Growth Factor (EGF)IBA 06/2017
1	Insulin (Novolin)FDA Link 06/2017
1	Insulin-Like PeptidesIBA 04/2017
1	Amiloride (Midamor)FDA LinkGeneric 02/2017
1	ethylisopropylamiloride (EIPA)IBA 02/2017
1	Neutral RedIBA 02/2017
1	Histone Deacetylase InhibitorsIBA 02/2017
1	EpitopesIBA 01/2017
1	Plicamycin FDA Link 01/2017
1	Sp1 Transcription FactorIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	methoxypolyethyleneglycol- poly(lactic- co- glycolic acid)IBA 01/2017
1	mithramycin AIBA 01/2017
1	GalactosidasesIBA 11/2016
1	IMB5046IBA 11/2016
1	desferrioxamine-human serum albumin conjugateIBA 09/2016
1	TuftsinIBA 12/2014
1	geldanamycinIBA 01/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014
1	Proteasome InhibitorsIBA 07/2013
1	Bortezomib (Velcade)FDA Link 07/2013
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 04/2013
1	NGR peptideIBA 03/2013

Therapy/Procedure

23	Therapeutics 09/2021 - 07/2004
6	Drug Therapy (Chemotherapy) 01/2020 - 12/2004
3	Intravenous Injections 03/2012 - 06/2005
1	Immunomodulation 09/2021
1	Injections 01/2019
1	Immunotherapy 01/2017